• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial.

作者信息

Buxton Alfred E, Lee Kerry L, Hafley Gail E, Wyse D George, Fisher John D, Lehmann Michael H, Pires Luis A, Gold Michael R, Packer Douglas L, Josephson Mark E, Prystowsky Eric N, Talajic Mario R

机构信息

Brown Medical School, Providence, RI, USA.

出版信息

Circulation. 2002 Nov 5;106(19):2466-72. doi: 10.1161/01.cir.0000037224.15873.83.

DOI:10.1161/01.cir.0000037224.15873.83
PMID:12417544
Abstract

BACKGROUND

Fifty percent of deaths in patients with coronary disease occur suddenly. Although many factors correlate with increased mortality, there is little information regarding the influence of these factors on mode of death. As such, optimum methods to determine patients most likely to benefit from implantable defibrillator therapy are unclear.

METHODS AND RESULTS

We analyzed the relation of ejection fraction and inducible ventricular tachyarrhythmias to mode of death in all 1791 patients enrolled in the Multicenter Unsustained Tachycardia Trial who did not receive antiarrhythmic therapy. Total mortality and arrhythmic deaths/cardiac arrests occurred more frequently in patients with ejection fraction <30% than in those with ejection fraction of 30% to 40%. The percentage of deaths classified as arrhythmic was similar in patients with ejection fraction <30% or > or =30%. The relative contribution of arrhythmic events to total mortality was significantly higher in patients with inducible tachyarrhythmia (58% of deaths in inducible patients versus 46% in noninducible patients, P=0.004). The higher percentage of events that were arrhythmic among patients with inducible tachyarrhythmia appeared more distinct among patients with an ejection fraction > or =30% (61% of events were arrhythmic among inducible patients with ejection fraction > or =30% and only 42% among noninducible patients, P=0.002).

CONCLUSIONS

Both low ejection fraction and inducible tachyarrhythmias identify patients with coronary disease at increased mortality risk. Ejection fraction does not discriminate between modes of death, whereas inducible tachyarrhythmia identifies patients for whom death, if it occurs, is significantly more likely to be arrhythmic, especially if ejection fraction is > or =30%.

摘要

相似文献

1
Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial.
Circulation. 2002 Nov 5;106(19):2466-72. doi: 10.1161/01.cir.0000037224.15873.83.
2
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.射血分数在预测冠心病患者猝死风险方面的局限性:来自MUSTT研究的经验教训。
J Am Coll Cardiol. 2007 Sep 18;50(12):1150-7. doi: 10.1016/j.jacc.2007.04.095. Epub 2007 Sep 4.
3
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.通过电生理测试来识别有冠心病猝死风险的患者。多中心非持续性心动过速试验研究者。
N Engl J Med. 2000 Jun 29;342(26):1937-45. doi: 10.1056/NEJM200006293422602.
4
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).多中心非持续性心动过速试验(MUSTT)中事件的指定与分布
Am J Cardiol. 2007 Jul 1;100(1):76-83. doi: 10.1016/j.amjcard.2007.02.055. Epub 2007 May 11.
5
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.一项关于冠心病患者猝死预防的随机研究。多中心非持续性心动过速试验研究人员。
N Engl J Med. 1999 Dec 16;341(25):1882-90. doi: 10.1056/NEJM199912163412503.
6
Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT).
Circulation. 2002 Nov 19;106(21):2694-9. doi: 10.1161/01.cir.0000038499.22687.39.
7
New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.针对左心室功能不全患者的心脏性猝死新的一级预防试验:SCD-HEFT和MADIT-II。
Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. doi: 10.1016/s0002-9149(99)00040-5.
8
Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.血管紧张素转换酶抑制剂对既往有心肌梗死、非持续性室性心动过速及左心室功能减退患者的电生理和临床效应。 MUSTT研究者。多中心非持续性心动过速试验。
Am J Cardiol. 2001 Mar 15;87(6):716-20. doi: 10.1016/s0002-9149(00)01489-2.
9
Screening and therapy for patients with nonsustained ventricular tachycardia.非持续性室性心动过速患者的筛查与治疗
Am J Cardiol. 2000 Nov 2;86(9A):34K-39K. doi: 10.1016/s0002-9149(00)01290-x.
10
Prognostic significance of nonsustained ventricular tachycardia after revascularization.
J Cardiovasc Electrophysiol. 2002 Apr;13(4):342-6. doi: 10.1046/j.1540-8167.2002.00342.x.

引用本文的文献

1
Extreme Risk of Sudden Cardiac Death within Three Months after Revascularization in Patients with Ischemic Left Ventricular Systolic Dysfunction.缺血性左心室收缩功能障碍患者血管重建术后三个月内心脏性猝死的极高风险
Rev Cardiovasc Med. 2023 Oct 18;24(10):294. doi: 10.31083/j.rcm2410294. eCollection 2023 Oct.
2
Cardiac Magnetic Resonance and Ventricular Arrhythmia Risk Assessment in Chronic Ischemic Cardiomyopathy: An Unmet Need?慢性缺血性心肌病中心脏磁共振成像与室性心律失常风险评估:一项未满足的需求?
Rev Cardiovasc Med. 2022 Jun 28;23(7):246. doi: 10.31083/j.rcm2307246. eCollection 2022 Jul.
3
Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions.
植入式心脏复律除颤器心动过速治疗:过去、现在与未来方向
J Cardiovasc Dev Dis. 2024 Mar 20;11(3):92. doi: 10.3390/jcdd11030092.
4
Incremental prognostic value of left atrial and biventricular feature tracking in dilated cardiomyopathy: a long-term study.左心房和双心室应变追踪技术在扩张型心肌病中的预后价值:一项长期研究。
J Cardiovasc Magn Reson. 2023 Dec 7;25(1):76. doi: 10.1186/s12968-023-00967-4.
5
Cardiac resynchronization therapy with a defibrillator in non-ischemic and ischemic patients for primary and secondary prevention of sudden cardiac death: Analysis of the Japan cardiac device treatment registry database.植入式心脏除颤器用于非缺血性和缺血性患者心脏再同步治疗以进行心脏性猝死的一级和二级预防:日本心脏器械治疗注册数据库分析
J Arrhythm. 2023 Aug 24;39(5):757-765. doi: 10.1002/joa3.12916. eCollection 2023 Oct.
6
Cardiac defibrillator implantation in patients with syncope and inducible ventricular arrhythmia: insights from the German Device Registry.心脏除颤器植入术在晕厥和可诱导性室性心律失常患者中的应用:来自德国器械注册研究的启示。
Sci Rep. 2023 Jul 27;13(1):12182. doi: 10.1038/s41598-023-37440-2.
7
Implantable Cardioverter-Defibrillator for Primary Prevention in Asia.亚洲用于一级预防的植入式心脏复律除颤器
JACC Asia. 2023 Mar 7;3(3):321-334. doi: 10.1016/j.jacasi.2022.11.014. eCollection 2023 Jun.
8
Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function.多基因风险评分可预测伴收缩功能保留的冠心病患者的猝死风险。
J Am Coll Cardiol. 2022 Aug 30;80(9):873-883. doi: 10.1016/j.jacc.2022.05.049.
9
Dual-chamber ICD for left bundle branch area pacing: the cardiac resynchronization and arrhythmia sensing via the left bundle (cross-left) pilot study.双腔 ICD 用于左束支区域起搏:通过左束(交叉左)先导研究进行心脏再同步和心律失常感知。
J Interv Card Electrophysiol. 2023 Jun;66(4):905-912. doi: 10.1007/s10840-022-01342-6. Epub 2022 Aug 16.
10
The scar: the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias.瘢痕:完美风暴中的风——深入了解起源于心室心律失常的神秘活体组织。
J Interv Card Electrophysiol. 2023 Jan;66(1):27-38. doi: 10.1007/s10840-021-01104-w. Epub 2022 Jan 24.